COVID-19 infection after autologous stem cell transplantation for systemic sclerosis.

Autor: Henes JC; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany joerg.henes@med.uni-tuebingen.de., Martac I; Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany., Vogel W; Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany., Lengerke C; Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany., Klein R; Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany., Hensen L; Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany., Pecher AC; Centre for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases and Department of Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tubingen, Tuebingen, Germany.
Jazyk: angličtina
Zdroj: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Jul; Vol. 82 (7), pp. 996-998. Date of Electronic Publication: 2023 Mar 08.
DOI: 10.1136/ard-2023-223915
Abstrakt: Competing Interests: Competing interests: None declared.
Databáze: MEDLINE